Inflammatory cytokines in pediatric cardiac surgery and variable effect of the hemofiltration process

Cardiac surgery with cardiopulmonary bypass (CPB) elicits an inflammatory response and has a multitude of biological consequences, ranging from subclinical organ dysfunction to severe multiorgan failure. Pediatric patients are more prone to have a reaction that can jeopardize their outcome. Cytokines are supposed to be important mediators in this response: limiting their circulating levels is, therefore, appealing. We investigated the pattern of cytokine release during pediatric operation for congenital heart anomalies in 20 patients, and the effect of hemofiltration. Tumor necrosis factor a (TNF-α) was elevated after anesthesia induction and showed significant decrease during CPB. Hemofiltration reduced its concentration, but the effect disappeared on the following day. Interleukin-1 (IL-1) increased slowly at the end of CPB and hemofiltration had no effect. Interleukin-6 (IL-6) showed a tendency toward augmentation during rewarming and hemofiltration did not significantly affect the course. Soluble interleukin-6 receptor (sIL-6r) had a pattern similar to TNF-α, but hemofiltration had no effect. On the other hand, interleukin-8 (IL-8) behaved like IL-6. Our findings suggest that baseline clinical status, anesthetic drugs, and maneuvers before incision may elicit a cytokine response, whereas rewarming is a critical phase of CPB. Hemofiltration is effective in removal of TNF-α, but its role is debatable for the control of IL-1, IL-6, sIL-6r and IL-8 levels.

[1]  T. Carrel,et al.  Elimination of proinflammatory cytokines in pediatric cardiac surgery: analysis of ultrafiltration method and filter type. , 2004, The Journal of thoracic and cardiovascular surgery.

[2]  H. Kubo,et al.  Effects of rewarming on nuclear factor-&kgr;B and interleukin 8 expression in cold-preserved alveolar epithelial cells , 2003, Transplantation.

[3]  E. Pehkonen,et al.  Inflammatory cytokines and soluble receptors after coronary artery bypass grafting. , 2001, Cytokine.

[4]  O. K. Hansen,et al.  Tissue Injury and the Inflammatory Response to Pediatric Cardiac Surgery with Cardiopulmonary Bypass: A Descriptive Study , 2001, Anesthesiology.

[5]  L. Tritapepe,et al.  A circuit to perform a combined ultrafiltration procedure in pediatric open heart surgery. , 2000, The Annals of thoracic surgery.

[6]  P Menu,et al.  Circulating soluble gp130, soluble IL-6R, and IL-6 in patients undergoing cardiac surgery, with or without extracorporeal circulation. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  T. Mayumi,et al.  Effect of ultrafiltration during cardiopulmonary bypass for pediatric cardiac surgery. , 1998, Artificial organs.

[8]  N. Nathan,et al.  Plasma leukaemia inhibitory factor, interleukin 6 and soluble interleukin 6 receptor levels during cardiopulmonary bypass with extracorporeal circulation. , 1998, Cytokine.

[9]  J. Vincent,et al.  Clinical Investigations: SurgeryInflammatory Response to Cardiopulmonary Bypass: Mechanisms Involved and Possible Therapeutic Strategies , 1997 .

[10]  T. Ishiko,et al.  IL-6 and soluble IL-6 receptor levels change differently after surgery both in the blood and in the operative field. , 1997, Cytokine.

[11]  H. Lindberg,et al.  Release of soluble tumour necrosis factor alpha receptors during and after paediatric cardiopulmonary bypass. Correlation with haemodynamic and clinical variables. , 1996, Cytokine.

[12]  D. Mangano,et al.  Inflammatory Cascade: A Final Common Pathway for Perioperative Injury? , 1996, Anesthesiology.

[13]  W. Mcbride,et al.  The balance of pro and anti-inflammatory cytokines in plasma and bronchoalveolar lavage (BAL) at paediatric cardiac surgery. , 1996, Cytokine.

[14]  H. Lindberg,et al.  Release of interleukin 6 and activation of complement during and after paediatric cardiopulmonary bypass. Effect of autotransfusion of shed mediastinal blood and ultrafiltration. , 1996, Cytokine.

[15]  W. Greeley,et al.  Hemofiltration during Cardiopulmonary Bypass in Pediatric Cardiac Surgery: Effects on Hemostasis, Cytokines, and Complement Components , 1994, Anesthesiology.

[16]  M. Dehoux,et al.  Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. , 1994, The Journal of thoracic and cardiovascular surgery.

[17]  G. von Bernuth,et al.  Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. , 1993, The Journal of thoracic and cardiovascular surgery.

[18]  L. Casey Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. , 1993, The Annals of thoracic surgery.

[19]  S Westaby,et al.  Inflammatory response to cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[20]  F. Sebening,et al.  Surgery for Tricuspid Insufficiency: Long-Term Follow-Up After De Vega Annuloplasty , 1993, The Thoracic and cardiovascular surgeon.

[21]  S. Akira,et al.  Interleukin-6 and its receptor: a paradigm for cytokines. , 1992, Science.

[22]  Simon C Watkins,et al.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide. , 1992, Science.

[23]  F. Maly,et al.  Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass without clinical relevance in adults. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[24]  J. Gaynor,et al.  Use of modified ultrafiltration after repair of congenital heart defects. , 1998, Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual.

[25]  G. Valen,et al.  Pathophysiology and mediators of ischemia-reperfusion injury with special reference to cardiac surgery. A review. , 1993, Scandinavian journal of thoracic and cardiovascular surgery. Supplementum.